Indeed, in CD34+-humanized NSG mice, antibody-mediated depletion of T cells led to the development of EBV-associated tumors, suggesting that T cell-mediated immunity can control EBV infection in this setting (143). This evidence concerns the gene CD34 and Epstein-Barr virus infection.